The DOI matches its Crossref record.
Angiostatin: A Circulating Endothelial Cell Inhibitor That Suppresses Angiogenesis and Tumor Growth
Abstract
A central problem in tumor growth is how tumor cells switch to the angiogenic phenotype. Virtually all solid tumors are angiogenic and neovascularized by the time they are detectable in animals and humans. However, at the time they originate, spontaneously arising tumor cells are not usually angiogenic (Folkman et al. 1989). Tumors formed by these cells are of small volumes limited to a few cubic millimeters and restricted to an existence in this in situ stage for months or years. Further expansion of such a tumor depends on its induction of new capillary blood vessels that converge toward the tumor. This switch to angiogenesis is usually accomplished by a subset of tumor cells within the in situ lesion. The new microvessels that are recruited provide a neovascular meshwork which supports the growth, and facilitates invasion and metastasis of the rapidly expanding tumor...
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Risau, W. (1997) · Nature · doi:10.1038/386671a0 · Cited by 5,727
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
Self-citationCXC chemokines in angiogenesis
Belperio, J. A., Keane, M. P., Arenberg, D. A., Addison, C. L., Ehlert, J. E., Burdick, M. D., & Strieter, R. M. (2000) · Journal of Leukocyte Biology · doi:10.1189/jlb.68.1.1 · Cited by 804
Antiangiogenesis in cancer therapy—endostatin and its mechanisms of action
FOLKMAN, J. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.11.015 · Cited by 658
Self-citationA history of exploring cancer in context
Maman, S., & Witz, I. P. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0006-7 · Cited by 502
Cha, S., Knopp, E. A., Johnson, G., Wetzel, S. G., Litt, A. W., & Zagzag, D. (2002) · Radiology · doi:10.1148/radiol.2231010594 · Cited by 525
Benjamin, L. E., & Keshet, E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8761 · Cited by 506
Li, C.-Y., Shan, S., Huang, Q., Braun, R. D., Lanzen, J., Hu, K., Lin, P., & Dewhirst, M. W. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.2.143 · Cited by 334
Mechanisms of ATP release and signalling in the blood vessel wall
Lohman, A. W., Billaud, M., & Isakson, B. E. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs187 · Cited by 302
PROGNOSTIC MARKERS IN BLADDER CANCER: A CONTEMPORARY REVIEW OF THE LITERATURE
STEIN, J. P., GROSSFELD, G. D., GINSBERG, D. A., ESRIG, D., FREEMAN, J. A., FIGUEROA, A. J., SKINNER, D. G., & COTE, R. J. (1998) · Journal of Urology · doi:10.1016/s0022-5347(01)62747-2 · Cited by 271
Metadata
- Authors
- O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Cao, Y., Moses, M., Lane, W. S., Sage, E. H., & Folkman, J.
- Venue
- Cold Spring Harbor Symposia on Quantitative Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 1994-01-01
- Volume
- 59
- Issue
- 0
- Pages
- 471-482
- ISSN
- 0091-7451 (ISSN-L)
- 1943-4456
- OpenAlex
- W2084104262
- Cited by
- 216
- References
- 0
- Type
- posted content
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.